Early Phase Clinical Trials | Hackensack Meridian Health | NJ   

Early Phase Clinical Trials Provide New Hope for Children and Families Facing Pediatric Cancer

Researchers participating in 25 clinical trials for brain tumors, blood cancers, hematologic disorders, and solid tumors

 Early Phase Clinical Trials

Hackensack Meridian Children’s Health’s Pediatric Hematology Oncology team continues to lead in pediatric cancer research. The team is bringing novel treatments — and new hope — to children and families across New Jersey through their participation in 25 clinical trials for brain tumors, blood cancers, hematologic disorders, and solid tumors. 

“Our pediatric cancer experts are dedicated to advancing clinical research and finding new ways to treat all types of pediatric cancers,” said Alfred Gillio, M.D., director, Children’s Cancer Institute, Hackensack Meridian Children’s Health, and chief, Pediatric Stem Cell and Cellular Therapy Division at Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center. “Through our research, we hope to push the science forward and improve cure rates while offering promising treatment options to our young patients.”

“We understand the impact a pediatric cancer diagnosis can have on children and families,” said Ihor Sawczuk, M.D., FACS, president of Academics, Research and Innovation, Hackensack Meridian Health. “With every study and every participant, we get one step closer to finding a cure — and our mission is to give our young patients access to the latest, most promising cancer therapies today, when they need them most.”

Principal investigators for these early-stage clinical trials from Hackensack Meridian Children’s Health include Derek Hanson, M.D., Katharine Offer, M.D., Burton Appel, M.D., Jing Chen, M.D., and Alfred Gillio, M.D. 

Current clinical trials include:

Brain and Nervous System Cancers 

Blood Cancers and Hematologic Disorders

Solid Tumors

U.S. News & World Report 2023-2024 Cancer Best Hospitals

We use cookies to improve your experience. Please read our Privacy Policy or click Accept.